Tikun Olam Europe

Tikun Olam Europe was founded in 2018 in Greece, utilizing country’s potential to become an international center for the production and trading of innovative finished medical cannabis products under prescription, based on the Tikun Olam Israel know-how. Tikun Olam Israel is a pioneering company in research, development, and production of medical cannabis products worldwide, with more than 17 years of clinical and laboratory studies, with an extensive patient database. Tikun Olam Europe with a total investment of over €47m, in state-of-the-art facilities of 56,000m2, is transforming the healthcare landscape with its finished medical cannabis products under prescription. Its activity is fully aligned with the Greek legislation provisions for the cultivation and processing of cannabis. Tikun Olam Europe develops finished medical cannabis products under prescription that are produced in an EU-GMP environment under strict control standards and procedures which ensure high quality and safety.  Tikun Olam Europe finished medical cannabis products under prescription offer support for serious conditions, such as Cancer, Multiple Sclerosis, HIV, Hepatitis C, Chronic Neuropathic Pain.